Can WeightWatchers survive the Ozempic era?
Description
Two weeks ago, the WeightWatchers board ousted CEO Sima Sistani, who helmed the company for two-and-a-half years, appointing board member Tara Comonte interim CEO. During that time, the company has radically altered its business model to stay competitive in the Ozempic era. Cohost Yasmin Gange analyzes what this leadership change signals for the company’s strategy. Also, ‘Fast Company’ associate editor David Salazar talks with Harvey Mason Jr., CEO of the Recording Academy. His tenure of the past 3 years comes amid a cultural discussion about whether or not the Grammys and the Academy are still relevant. They chatted about diversifying the Grammy voting process, advocating for artists, and how Mason feels about AI in the music industry.
United States
